SAN DIEGO — GLP-1 agonists may be protective against hip fracture when administered for the treatment of type 2 diabetes, according to results presented here.
Plans and pricing Video Back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback